Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Arch Toxicol. 2017 Oct;91(10):3365-3372. doi: 10.1007/s00204-017-1950-9. Epub 2017 Mar 13.
The maintenance of cellular homeostasis is a complex process that is governed by the receipt of prototypical growth and death signals. The endogenous functions of aryl hydrocarbon receptor (AHR) in cellular homeostasis are not well understood. We aimed to establish whether the disturbance of endogenously activated AHR can influence cell growth, and if so, what mechanism(s) are involved. Cell growth was measured in mouse hepatoma Hepa-1 wild-type and cytochrome P4501A1 (CYP1A1)-deficient c37 cells. In other sets of experiments, HepG2 cells were exposed to different doses of FICZ (0.01nM-1 µM) alone or in combination with 50 nM of the CYP1A1 inhibitor 3'methoxy-4'nitro-flavone (MNF). CYP1A1 enzyme activity, cell viability, oxidative stress, and several endpoints of apoptosis were measured. FICZ treatment at a high concentration or in combination with MNF induced sustained CYP1A1 activity and led to oxidative stress and activation of apoptosis via a mitochondrial-dependent pathway. In comparison with the wild-type Hepa-1 cells, c37 cells lacking CYP1A1 activity proliferated faster in normal medium which contains trace levels of FICZ. Besides, in HepG2 cells, FICZ stimulated cell growth at low concentrations but inhibited cell growth at high concentrations. Based on these findings, we propose that CYP1A1 inhibitors, by increasing the levels of the endogenous ligand FICZ, change the cell growth kinetics and trigger cell death and apoptosis through a mitochondrial-dependent pathway. Since AHR controls multiple cellular functions, a wide range of toxicity can be expected by disturbing its endogenous functions.
细胞内稳态的维持是一个复杂的过程,受典型生长和死亡信号的接收调控。芳基烃受体(AHR)在细胞内稳态中的内源性功能尚不清楚。我们旨在确定内源性激活的 AHR 干扰是否会影响细胞生长,如果是,涉及哪些机制。在野生型小鼠肝癌 Hepa-1 和细胞色素 P4501A1(CYP1A1)缺陷 c37 细胞中测量细胞生长。在其他实验中,将 HepG2 细胞暴露于不同剂量的 FICZ(0.01nM-1µM)单独或与 50nM CYP1A1 抑制剂 3'-甲氧基-4'-硝基黄酮(MNF)联合使用。测量 CYP1A1 酶活性、细胞活力、氧化应激和几种细胞凋亡终点。高浓度的 FICZ 处理或与 MNF 联合使用会诱导持续的 CYP1A1 活性,并通过线粒体依赖性途径导致氧化应激和细胞凋亡激活。与野生型 Hepa-1 细胞相比,缺乏 CYP1A1 活性的 c37 细胞在正常培养基中(其中含有痕量的 FICZ)增殖更快。此外,在 HepG2 细胞中,FICZ 在低浓度下刺激细胞生长,但在高浓度下抑制细胞生长。基于这些发现,我们提出 CYP1A1 抑制剂通过增加内源性配体 FICZ 的水平改变细胞生长动力学,并通过线粒体依赖性途径触发细胞死亡和凋亡。由于 AHR 控制多种细胞功能,干扰其内源性功能可能会产生广泛的毒性。